"The Scripps Research Translational Institute was founded in 2007 with one essential aim—to individualize healthcare by leveraging the remarkable progress being made in human genomics and combining it with the power of wireless digital technologies. Bringing together scientists and clinical investigators, the Translational Institute fosters highly collaborative multidisciplinary research with the greatest potential to transform the practice of healthcare and improve human health."

During the past decade, Scripps Translational Science Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scripps Translational Science Institute" #1 collaborator was "CareEvolution Healthcare Technology" with 2 trials as a collaborator, "Scripps Health" with 2 trials as a collaborator, "Aetna, Inc." with 1 trials as a collaborator, "Janssen Scientific Affairs, LLC" with 1 trials as a collaborator and "NeuroMetrix, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Scripps Translational Science Institute" are "Healthy" (2 trials), "Hypertension" (2 trials), "Antibodies Involved in Healthy Aging" (1 trials), "Atrial Fibrillation" (1 trials) and "Blood Pressure" (1 trials). Many other conditions were trialed in "Scripps Translational Science Institute" in a lesser frequency.

Most popular intervention types in "Scripps Translational Science Institute" are "Device" (4 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Colchicine" (1 trials), "Continuous glucose monitoring" (1 trials), "Control" (1 trials), "DM Pgm + device" (1 trials) and "Quell" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scripps Translational Science Institute" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Scripps Translational Science Institute". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 11 completed trials in Scripps Translational Science Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Scripps Translational Science Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".